Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4/13 cytokine trap

Biotechnology and Bioengineering

Volumn 90, Issue 5, 2005, Pages 568-577

  Clark, Kevin J R ^a,d   Griffiths, Jennifer ^c   Bailey, Kevin M ^c   Harcum, Sarah W ^a,b  

^a AMRL   (United States)

^b CLEMSON UNIVERSITY   (United States)

^c REGENERON PHARMACEUTICALS INC   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

Galactosylation; Quantitative real time PCR; Sialylation; TaqMan

Indexed keywords

FUSION TRAPS; GENE EXPRESSIONS; GLYCOSYLATION; OVARY CELLS;

BIOMEDICAL ENGINEERING; CELLS; CONCENTRATION (PROCESS); ENZYME KINETICS; GENES; GLUCOSE; ORGANIC ACIDS;

GENETIC ENGINEERING;

BETA1, 4 GALACTOSYLTRANSFERASE; CYTOKINE; GALACTOSE; GALACTOSYLTRANSFERASE; GLUCOSE; HYBRID PROTEIN; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 4; RECOMBINANT PROTEIN; SIALIDASE; UDP GALACTOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; ENZYME ACTIVITY; GENE EXPRESSION; GLYCOSYLATION; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SIALYLATION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GALACTOSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOSYLATION; INTERLEUKIN-13; INTERLEUKIN-4; N-ACETYLNEURAMINIC ACID; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; TRANSFERASES;

CRICETINAE; CRICETULUS GRISEUS;

EID: 19544383966     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.20439     Document Type: Article

References (58)

1. Andersen D, Joly J, Snedecor BR, inventors; Genentech, Inc., assignee. 2004 April 6. Metabolic rate shifts in fermentations expressing recombinant proteins. US patent 6,716,602.
2. Anumula KR. 1997. Highly sensitive pre-column derivatization procedures for quantitative determination of monosaccharides, sialic acids, and amino sugar alcohols of glycoproteins by reversed phase high-performance liquid chromatography. In: Townsend RR, Arland T, Hotchkiss J, editors. Techniques in glycobiology. New York: Marcel Dekker. p 349-357.
3. Baker KN, Rendall MH, Hills AE, Hoare M, Freedman RB, James DC. 2001. Metabolic control of recombinant protein N-glycan processing in NSO and CHO cells. Biotechnol Bioeng 73(3): 188-202.
4. Baum LG, Derbin K, Perillo NL, Wu T, Pang M, Uittenbogaart C. 1996. Characterization of terminal sialic acid linkages on human thymocytes. Correlation between lectin-binding phenotype and sialyltransferase expression. J Biol Chem 271(18): 10793-10799.
5. Berg W, Gutschkergdaniec G, Schauer R. 1985. Fluorescent staining of sialidases in polyacrylamide-gel electrophoresis and ultrathin-layer isoelectric-focusing. Anal Biochem 145(2):339-342.
6. Clark KRJ, Bailey KM, Griffiths J, Harcum SW, Method to quantify gene expression levels for glycosylation pathway genes in CHO cells. Appl Biochem Biotechnol (in press).
7. Clark KRJ, Chaplen FWR, Harcum SW. 2004. Temperature effects on product quality related enzymes in batch CHO cell cultures producing recombinant tPA. Biotechnol Progr 20(6): 1888-1892.
8. deZengotita VM, Miller WM, Aunins JG, Zhou WC. 2000. Phosphate feeding improves high-cell-concentration NSO myeloma culture performance for monoclonal antibody production. Biotechnol Bioeng 69 (5):566-576.
9. Economides AN, Carpenter LR, Rudge JS, Wong V, Koehler-Stec EM, Hartnett C, Pyles EA, Xu XB, Daly TJ, Young MR, Fandl JP, Lee F, Carver S, McNay J, Bailey K, Ramakanth S, Hutabarat R, Huang TT, Radziejewski C, Yancopoulos GD, Stahl N. 2003. Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat Med 9(1):47-52.
10. Ferrari J, Harris R, Warner TG. 1994. Cloning and expression of a soluble sialidase from Chinese hamster ovary cells - sequence alignment similarities to bacterial sialidases. Glycobiology 4(3):367-373.
11. Freeman WM, Walker SJ, Vrana KE. 1999. Quantitative RT-PCR: pitfalls and potential. BioTechniques 26(1):112-125.
12. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. 2003. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31:3784-3788.
13. Gawlitzek M, Conradt HS, Wagner R. 1995. Effect of different cell culture conditions on the polypeptide integrity and N-glycosylation of a recombinant model glycoprotein. Biotechnol Bioeng 46:536-544.
14. Gawlitzek M, Ryll T, Lofgren J, Sliwkowski MB. 2000. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms. Biotechnol Bioeng 68(6):637-646.
15. Goochee CF, Gramer MJ. 1993. Glycosidase activities in Chinese hamster ovary cell lysate and cell culture supernatant. Biotechnol Prog 9: 366-373.
16. Grahn A, Larson G. 2001. Identification of nine alternatively spliced α2,3-sialyltransferase, ST3Gal IV, transcripts and analysis of their expression by RT-PCR and laser-induced fluorescent capillary electrophoresis (LIF-CE) in twenty-one human tissues. Glycoconjugate J 18(10):759-767.
17. Gramer MJ, Goochee C, Chock VY, Brousseau DT, Sllwkowski MB. 1995a. Removal of sialic acid from a glycoprotein in CHO cell culture supernatant by action of an extracellular CHO cell sialidase. BioTechnology 13:692-698.
18. Gramer MJ, Goochee CF, Chock VY, Brousseau DT, Sliwkowski MB. 1995b. Removal of sialic acid from a glycoprotein in CHO cell-culture supernatant by action of an extracellular CHO cell sialidase. BioTechnology 13(7):692-698.
19. Grillari J, Fortschegger K, Grabherr RM. Hohenwarter O, Kunert R, Katinger H. 2001. Analysis of alterations in gene expression after amplification of recombinant genes in CHO cells. J Biotechnol 87(1): 59-65.
20. Gu XJ, Harmon BJ, Wang DIC. 1997a. Site- and branch-specific sialylation of recombinant human interferon-γ in Chinese hamster ovary cell culture. Biotechnol Bioeng 55(2):390-398.
21. Gu XJ, Wang DIC. 1998, Improvement of interferon-γ sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine. Biotechnol Bioeng 58(6):642-648.
22. Gu XJ, Xie LZ, Harmon BJ, Wang DIC. 1997b. Influence of Primatone RL supplementation on sialylation of recombinant human interferon-γ produced by Chinese hamster ovary cell culture using serum-free media. Biotechnol Bioeng 56(4):353-360.
23. Harduin-Lepers A, Stokes DC, Steelant WFA, Samyn-Petit B, Krzewinski-Recchi MA, Vallejo-Ruiz V, Zanetta JP, Auge C, Delannoy P. 2000. Cloning, expression and gene organization of a human Neu4Ac α2-3Gal β1-3GalNAc α2,6-sialyltransferase: hST6GalNAc IV. Biochem J 352:37-47.
24. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. 2001. The human sialyltransferase family. Biochimie 83(8):727-737.
25. Hayter PM, Curling EMA, Baines AJ, Jenkins N, Salmon I, Strange PG, Tong MM, Bull AT. 1992. Glucose-limited chemostat culture of Chinese hamster ovary cells producing recombinant human interferon-γ. Biotechnol Bioeng 39:327-335.
26. Hayter PM, Curling EMA, Gould ML, Baines AJ, Jenkins N, Salmon I, Strange PG, Bull AT. 1993. The effect of the dilution rate on CHO cell physiology and recombinant interferon-γ production in glucose-limited chemostat culture. Biotechnol Bioeng 42:1007-1085.
27. Hills AE, Patel A, Boyd P, James DC. 2001. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NSO cells. Biotechnol Bioeng 75(2):239-251.
28. Hinton DA, Evans SC, Shur BD. 1995. Altering the expression of cell-surface β1,4-galactosyltransferase modulates cell growth. Exp Cell Res 219(2):640-649.
29. Hooker AD, Goldman MH, Markham NH, James DC, Ison AP, Bull AT, Strange PG, Salmon I, Baines AJ, Jenkins N. 1995. N-Glycans of recombinant human interferon-γ change during batch culture of Chinese hamster ovary cells. Biotechnol Bioeng 48:639-648.
30. Hu WS, Zhou WC, Europa LF. 1998. Controlling mammalian cell metabolism in bioreactors. J Microbiol Biotechnol 8(1):8-13.
31. Kaszubska W, Zhang HY, Patterson RL, Suhar TS. Uchic ME, Dickinson RW, Schaefer VG, Haasch D, Janis RS, DeVries PJ, Okasinski GF, Meuth JL. 2000. Expression, purification, and characterization of human recombinant thrombopoietin in Chinese hamster ovary cells. Protein Expr Purif 18(2):213-220.
32. Kim JM, Sohn HY, Oh JH, Kim JG, Kim NS, Kim YS. 2003. Characterization of human WNT7b gene and its up regulation in gastric cancer cell lines. Exp Oncol 25(3):211-215.
33. Kitagawa H, Mattel MG, Paulson JC. 1996. Genomic organization and chromosomal mapping of the Gal β1,3GalNAc/Gal β1,4GlcNAc α2,3-sialyltransferase. J Biol Chem 271(2):931-938.
34. Kotani N, Asano M, Iwakura Y, Takasaki S. 2001. Knockout of mouse β1,4-galactosyltransferase-l gene results in a dramatic shift of outer chain moieties of N-glycans from Type 2 to Type 1 chains in hepatic membrane and plasma glycoproteins. Biochem J 357:827-834.
35. Kunkel JP, Jan DCH, Jamieson JC, Butler M. 1998. Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. J Biotechnol 62:55-71.
36. Lamotte D, Buckberry L, Monaco L, Soria M, Jenkins N, Engasser J-M, Marc A. 1999. Na-butyrate increases the production and α2,6-sialylation of recombinant interferon-γ expressed by α2,6-sialyltransferase engineered CHO cells. Cytotechnology 29(1):55-64.
37. Lee DE, Ha BJ, Kim SJ, Park JS, Yoo RA, Oh MS, Kim HS. 1996. Carbohydrate structure of N- and O-linked oligosaccharides of human erythropoietin expressed in Chinese hamster ovary cells. J Biochem Mol Biol 29(3):266-271.
38. Lee JH, Sundaram S, Shaper NL, Raju TS, Stanley P. 2001. Chinese hamster ovary (CHO) cells may express six β4-galactosyltransferases (β4GalTs): consequences of the loss of functional β4GalT-l; β4GalT-6; or both in CHO glycosylation mutants. J Biol Chem 276(17): 13924-13934.
39. Masibay AS, Damewood GP, Boeggeman E, Qasba PK. 1991. Expression of β1,4-galactosyltransferase gene during 3T3 cell growth. Biochim Biophys Acta 1090(2):230-234.
40. Monaco L, Marc N, Eon-Duval A, Acerbis G, Distefano G, Lamotte D, Engasser J-M, Soria M, Jenkins N. 1996. Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ. Cytotechnology 22: 197-203.
41. Rajan N, Tsarbopoulos A, Kumarasamy R, Odonnell R, Taremi SS, Baldwin SW, Seelig GF, Fan XD, Pramanik B, Le HV. 1995. Characterization of recombinant human interleukin-4 receptor from CHO cells - role of N-linked oligosaccharides. Biochem Biophys Res Commun 206(2):694-702.
42. Rajput B, Shaper NL, Shaper JH. 1996. Transcriptional regulation of murine β1,4-galactosyltransferase in somatic cells: analysis of a gene that serves both a housekeeping and a mammary gland-specific function. J Biol Chem 271(9):5131-5142.
43. Stahl N, Economides A, Carpenter LR, Wong V, Rudge J, Yancopoulos GD. 1999. Cytokine traps: heteromeric receptor-based protein therapeutics that function as high-affinity blockers of cytokine action. FASEB J 13(7):A1585-A1585.
44. Stahl N, Yancopoulos GD, inventors; Regeneron Pharmaceuticals, Inc., assignee. 2002 October 29. Receptor based antogonists and methods of making and using. US patent 6,472,179.
45. Suzuki T, Higgins P, Crawford D. 2000. Control seletion of RNA quantification. BioTechniques 29(2):332-337.
46. Taniguchi A, Hasegawa Y, Higai K, Matsumoto K. 2000. Transcriptional regulation of human β-galactoside α2,6-sialyltransferase (hST6Gal I) gene during differentiation of the HL-60 cell line. Glycobiology 10(6):623-628.
47. Taniguchi A, Matsumoto K. 1999. Epithelial cell specific transcriptional regulation of human Gal β1,3GalNAc/Gal β1,4GlcNAc α2,3- sialyltransferase (hST3Gal IV) gene. Biochem Biophys Res Commun 257(2):516-522.
48. Taniguchi A, Morishima T, Tsujita Y, Matsumoto Y, Matsumoto K. 2003. Genomic structure, expression, and transcriptional regulation of human Gal β1,3 GalNAc α2,3-sialyltransferase gene. Biochem Biophys Res Commun 300(2):570-576.
49. Tsarbopoulos A, Pramanik BN, Nagabhushan TL, Covey TR. 1995. Structural analysis of the CHO-derived interleukin-4 by liquid-chromatography electrospray ionization mass spectrometry. J Mass Spectrom 30(12):1752-1763.
50. Wang P, Zhang J, Bian H, Wu P, Kuvelkar R, Rung TT, Crawley Y, Egan RW, Billah MM. 2004. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. Biochem J 380:425-433.
51. Warner TG, Chang J, Ferrari J, Harris R, McNerney T, Bennett G, Burnier J, Sliwkowski MB. 1993. Isolation and properties of a soluble sialidase from the culture fluid of Chinese hamster ovary cells. Glycobiology 3(5):455-463.
52. Weikert S, Papac D, Briggs J, Cowfer D, Tom S, Gawlitzek M, Lofgren J, Mehta S, Chisholm V, Modi N, Eppler S, Carroll K, Chamow S, Peers D, Berman P, Krummen L. 1999. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nat Biotechnol 17(11):1116-1121.
53. Wen DX, Svensson EC, Paulson JC. 1992. Tissue-specific alternative splicing of the β-galactoside α2,6-sialyltransferase gene. J Biol Chem 267(4):2512-2518.
54. Yallop CA, Norby PL, Jensen R, Reinbach H, Svendsen I. 2003. Characterisation of G418-induced metabolic load in recombinant CHO and BHK cells: effect on the activity and expression of central metabolic enzymes. Cytotechnology 42(2):87-99.
55. Yang M, Butler M. 2000. Effect of ammonia on CHO cell growth, erythropoietin production and glycosylation. Biotechnol Bioeng 68(4): 370-380.
56. Yang M, Butler M. 2002. Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms. Biotechnol Prog 18(1): 129-138.
57. Yuk IHY, Wang DIC. 2002. Glycosylation by Chinese hamster ovary cells in dolichol phosphate-supplemented cultures. Biotechnol Appl Biochem 36:141-147.
58. Zhang XQ, Lok SHL, Kon OL. 1998. Stable expression of human α-2,6-sialyltransferase in Chinese hamster ovary cells: functional consequences for human erythropoietin expression and bioactivity. Biochim Biophys Acta 1425(3):441-452.